Bio
Kashinath R.T. holds an MSc in Biochemistry and a Ph.D. in Biochemistry (Medical Faculty), and is a Fellow of the International College of Surgeons (FICS). He has served as Professor and Head of the Department of Biochemistry at Subbaiah Institute of Medical Sciences in Shimoga, India, and has held positions at Basaveshwara Medical College & Hospital, BLDE University, and Vijayanagara Institute of Medical Sciences. His research focuses on biochemical alterations in diabetes mellitus, including membrane lipid changes and the effects of organosulfur compounds. He has published multiple papers in the Global Journal of Medical Research and serves as a reviewer for the same journal.
Educational Journey
PhD • Biochemistry (Medical Faculty)
MSc • Biochemistry
Experience
Subbaiah Institute of Medical Sciences
Professor & HOD
0 - 0 • BiochemistryBasaveshwara Medical College & Hospital
0 - 0BLDE University
0 - 0Editors Role
Reviewer
Global Journal of Medical Research
2012 -Affiliations
International College of Surgeons
Fellow
Member since 0Research
Influence of Anti Diabetic Therapy on Plasma Lipid Profile and Its Relation to Erythrocyte Membrane Lipid Levels in Type 2 Diabetic Subjects
The diabetes induced dyslipidemia may lead to an alteration in RBC membrane cholesterol/phospholipids ratio in diabetic subjects resulting in an alteration in RBC membrane properties. It has been observed in our laboratory that diabetes induced dyslipidemia causes a change in RBC membrane lipid composition in type 2 diabetic subjects. The effect of various oral anti diabetic drugs and or Insulin therapy on diabetes induced RBC membrane lipid alteration is not established. Hence the present work was undertaken to study the influence of anti diabetic drugs and or Insulin on RBC membrane lipid composition in type 2 diabetic subjects. Blood samples from randomly selected type 2 diabetic subjects were collected after obtaining written consent. The plasma lipids as well as RBC membrane lipids were estimated. The study group include normal subjects (group-1), control diabetics diabetic subjects (group-2), diabetic subjects receiving oral drugs (group-3), diabetic subjects receiving insulin (group-4) and diabetic subjects receiving both oral drugs and insulin (group-5). The study suggest an increase in plasma lipid levels with a parallel raise in RBC membrane lipid composition in diabetic subjects and hypoglycemic drugs -insulin combined therapy regime may help to control the diabetic dyslipidemia induced erythrocyte membrane lipid alterations.
